Siemens AG Reassesses Majority Stake in Siemens Healthineers
Evaluating Economic Opportunities in Healthcare
In a recent interview with Handelsblatt newspaper, Siemens AG’s Chief Financial Officer, Ralf Thomas, revealed that the company is reevaluating its majority stake in medical technology subsidiary Siemens Healthineers. The German technology group is questioning whether the synergies with the manufacturer of MRI machines and laboratory systems justify a capital commitment of €45 billion, the value of Siemens’ 75% equity stake.
Assessing the Investment
Thomas emphasized that Siemens AG is examining the economic opportunities in the healthcare sector, which will ultimately determine the significance of Healthineers as an investment. The results of this assessment will be presented at a capital markets day in 2025. This move marks a shift from Siemens’ previous stance, where it maintained that it would retain the majority stake in Healthineers.
A Potential Sale on the Horizon?
Interestingly, Thomas hinted at the possibility of selling around 5% of Healthineers in the near future to finance the takeover of U.S. software company Altair. This development has sparked speculation about the future of Siemens’ stake in Healthineers.
Commitment to Mobility Train Division
In contrast, Thomas reaffirmed Siemens’ commitment to its Mobility train division, which has faced repeated calls from investors to be spun off. “The business is in good hands with us. I don’t see any need for us to part with it at the moment,” he stated.
A New Chapter for Siemens AG?
As Siemens AG navigates this critical juncture, one thing is clear: the company is poised to make significant changes to its portfolio. With the healthcare sector undergoing rapid transformation, Siemens’ decision to reassess its stake in Healthineers could have far-reaching implications for the industry.
Leave a Reply